CuraSen Therapeutics
CA - San CarlosBiotechnology
Focus: CuraSen Therapeutics is a small-molecule biotech focused on neurology indications including Parkinson's disease, cognitive impairment, and related disorders. The company operates at pre-revenue stage with a focused pipeline in early-to-mid clinical development.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
0
About CuraSen Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow CuraSen Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CST-2032, matching placebo for CST-2032, CST-107
Mild Cognitive Impairment (MCI)Clinical Trials (1)
NCT05033912A Study of CST-2032 in Subjects With Cognitive Impairment
Phase 1Help build intelligence for CuraSen Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.